Cited by 484Influenza Virus Research StudiesVaccine Coverage and HesitancyRespiratory viral infections research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Nichol, Kristin L., Wuorenma, J., von Sternberg, T.·1998·Archives of Internal Medicine

Open this paper in CoChat — free account

Abstract

BACKGROUND: Vaccination rates for healthy senior citizens are lower than those for senior citizens with underlying medical conditions such as chronic heart or lung disease. Uncertainty about the benefits of influenza vaccination for healthy senior citizens may contribute to lower rates of utilization in this group. OBJECTIVE: To clarify the benefits of influenza vaccination among low-risk senior citizens while concurrently assessing the benefits for intermediate- and high-risk senior citizens. METHODS: All elderly members of a large health maintenance organization were included in each of 6 consecutive study cohorts. Subjects were grouped according to risk status: high risk (having heart or lung disease), intermediate risk (having diabetes, renal disease, stroke and/or dementia, or rheumatologic disease), and low risk. Outcomes were compared between vaccinated and unvaccinated subjects after controlling for baseline demographic and health characteristics. RESULTS: There were more than 20000 subjects in each of the 6 cohorts who provided 147551 person-periods of observation. The pooled vaccination rate was 60%. There were 101 619 person-periods of observation for low-risk subjects, 15 482 for intermediate-risk, and 30 450 for high-risk subjects. Vaccination over the 6 seasons was associated with an overall reduction of 39% for pneumonia hospitalizations (P<.001), a 32% decrease in hospitalizations for all respiratory conditions (P<.001), and a 27% decrease in hospitalizations for congestive heart failure (P<.001). Immunization was also associated with a 50% reduction in all-cause mortality (P<.001). Within the risk subgroups, vaccine effectiveness was 29%, 32%, and 49% for high-, intermediate-, and low-risk senior citizens for reducing hospitalizations for pneumonia and influenza (for high and low risk, P< or =.002; for intermediate risk, P = .11). Effectiveness was 19%, 39%, and 33% (for each, P< or =.008), respectively, for reducing hospitalizations for all respiratory conditions and 49%, 64%, and 55% for reducing deaths from all causes (for each, P<.001). Vaccination was also associated with direct medical care cost savings of $73 per individual vaccinated for all subjects combined (P = .002). Estimates of cost savings within each risk group suggest that vaccination would be cost saving for each subgroup (range of cost savings of $171 per individual vaccinated for high risk to $7 for low risk), although within the subgroups these findings did not reach statistical significance (for each, P> or =.05). CONCLUSIONS: This study confirms that healthy senior citizens as well as senior citizens with underlying medical conditions are at risk for the serious complications of influenza and benefit from vaccination. All individuals 65 years or older should be immunized with this vaccine.

Integrity signals

Registry

Crossref · 10.1001/archinte.158.16.1769

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
State- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1996 and 1997.
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Sternberg, T. V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 995
The Efficacy of Influenza Vaccination in Elderly Individuals
Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 883
SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS
GLEZEN, W. P. (1982) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036250 · Cited by 449
Influenza Vaccination Programs for Elderly Persons: Cost-Effectiveness in a Health Maintenance Organization
Mullooly, J. P., Bennett, M. D., Hornbrook, M. C., Barker, W. H., Williams, W. W., Patriarca, P. A., & Rhodes, P. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00008 · Cited by 330
Current Procedural Terminology
Leong, F. T. L. (2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n176 · Cited by 326
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.
Lui, K., & Kendal, A. P. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.6.712 · Cited by 319
Immunization Policies and Vaccine Coverage Among Adults
Williams, W. W., HICKSON, M. A., KANE, M. A., Kendal, A. P., SPIKA, J. S., & HINMAN, A. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-616 · Cited by 300

Flagged first, then by citations

Show all 41 references

Sorted by citations

Items 201–300 of 480

Effectiveness of the influenza vaccination program for the elderly in Taiwan
Chiu, P.-J., Chen, C.-H., & Chih, Y.-C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.055 · Cited by 32
Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population
Capri, S., Barbieri, M., de Waure, C., Boccalini, S., & Panatto, D. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1438792 · Cited by 32
Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1)
Harris, K. M., Maurer, J., Black, C. L., Euler, G. L., & Kadiyala, S. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.112 · Cited by 32
Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age
Allsup, S. J., Gosney, M., Haycox, A. R., & Regan, M. (2003) · Health Technology Assessment · doi:10.3310/hta7240 · Cited by 32
Disparities in immunizations among elderly Medicare beneficiaries, 2000 to 2002
Bonito, A. J., Lenfestey, N. F., Eicheldinger, C. R., Iannacchione, V. G., & Campbell, L. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.04.004 · Cited by 32
Racial differences in influenza vaccination among older americans 1996–2000: longitudinal analysis of the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) survey
Østbye, T., Taylor, D. H., Lee, A. M. M., Greenberg, G., & Scoyoc, L. V. (2003) · BMC Public Health · doi:10.1186/1471-2458-3-41 · Cited by 31
Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50–64 years
Jiménez, R., Larrauri, A., Carrasco‐Garrido, P., Esteban‐Hernández, J., Gómez-López, L. I., & Gil, Á. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00425-0 · Cited by 31
Conventional Influenza Vaccination Is Not Associated with Complications in Working-Age Patients with Asthma or Chronic Obstructive Pulmonary Disease
Hak, E. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg027 · Cited by 31
Influenza-Associated Hospitalizations for Cardiovascular Diseases in the Tropics
Ang, L. W., Yap, J. J. L., Lee, V., Chng, W. Q., Jaufeerally, F. R., Lam, C. S. P., Cutter, J. L., Yeo, K. K., & Ma, S. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx001 · Cited by 31
Prevention and control of influenza in persons with chronic obstructive pulmonary disease
Plans-Rubió, P. (2007) · International Journal of COPD · doi:10.2147/copd.2007.2.1.41 · Cited by 30
Flu Vaccines and Patient Decision Making: What We Need to Know
Mayo, A. M., & Cobler, S. (2004) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2004.tb00390.x · Cited by 30
Influenza in Taiwan: seasonality and vaccine strain match.
Hsieh, Y., Chen, H., Yen, J.-J., Liu, D., Chang, L., Lu, C., Shao, P., Lee, C., & Huang, L. (2005) · PubMed · Cited by 30
Prognostic factors for influenza-associated hospitalization and death during an epidemic
Hak, E., VERHEIJ, T. J. M., van Essen, G. A., Lafeber, A. B., Grobbee, D. E., & Hoes, A. W. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005180 · Cited by 30
Should Patients With COPD Be Vaccinated?
Çimen, P., Unlu, M., Kıraklı, C., Katgı, N., Üçsular, F. D., Ayrancı, A., & Güçlü, S. Z. (2014) · Respiratory Care · doi:10.4187/respcare.03350 · Cited by 29
Influenza Vaccine Supply and Racial/Ethnic Disparities in Vaccination Among the Elderly
Yoo, B., Kasajima, M., Phelps, C. E., Fiscella, K. A., Bennett, N. M., & Szilagyi, P. G. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.09.028 · Cited by 29
Computation-Guided Discovery of Influenza Endonuclease Inhibitors
Chen, E., Swift, R. V., Alderson, N. B., Feher, V. A., Feng, G., & Amaro, R. E. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4003474 · Cited by 29
Coverage and predictors of influenza vaccination among adults with diabetes in Spain
Jiménez‐García, R., Jimenez, I., Carrasco‐Garrido, P., Hernández‐Barrera, V., López‐de‐Andrés, A., del Barrio, J. L., & de Miguel, Á. G. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.013 · Cited by 28
Vaccines against epidemic and pandemic influenza
Hoelscher, M., Gangappa, S., Zhong, W., Jayashankar, L., & Sambhara, S. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1139 · Cited by 29
Quality Indicators for the Management of Pneumonia in Vulnerable Elders
Rhew, D. C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-8_part_2-200110161-00013 · Cited by 29
Effects of previous influenza vaccination on subsequent readmission and mortality in elderly patients hospitalized with pneumonia
Herzog, N. S., Bratzler, D. W., Houck, P. M., Jiang, H., Nsa, W., Shook, C., & Weingarten, S. R. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00440-6 · Cited by 28
Traditional Chinese medicine therapy decreases the pneumonia risk in patients with dementia
Lin, S., Tsai, Y., Lo, P.-C., & Lai, J. (2016) · Medicine · doi:10.1097/md.0000000000004917 · Cited by 27
Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination
Menon, B., Gurnani, M., & Aggarwal, B. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01641.x · Cited by 28
Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities
You, J. H. S., Wong, W. C. W., Ip, M., Lee, N. L. S., & Ho, S. C. (2009) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.081885 · Cited by 28
Influenza vaccination among Canadians with chronic respiratory disease
Vozoris, N. T., & Lougheed, M. D. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.08.004 · Cited by 28
Reducing medical service utilization by encouraging vaccines
Berg, G. D., Thomas, E., Silverstein, S. M., Neel, C. L., & Mireles, M. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.07.001 · Cited by 27
Side Effects of Influenza Vaccination in Healthy Older People: A Randomised Single-Blind Placebo-Controlled Trial
Allsup, S. J., Gosney, M., Regan, M., Haycox, A. R., Fear, S. C., & Johnstone, F. C. W. (2001) · Gerontology · doi:10.1159/000052820 · Cited by 28
Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: Population-based cohort study in Japan
Hara, M., Sakamoto, T., & Tanaka, K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.027 · Cited by 27
Cost–effectiveness analysis of influenza vaccination for people aged 65 and over in Japan
Hoshi, S., Kondo, M., Honda, Y., & Okubo, I. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.067 · Cited by 27
Novel indole–flutimide heterocycles with activity against influenza PA endonuclease and hepatitis C virus
Zoidis, G., Giannakopoulou, E., Stevaert, A., Frakolaki, E., Myrianthopoulos, V., Fytas, G., Mavromara, P., Mikros, E., Bartenschlager, R. F. W., Vassilaki, N., et al. (2015) · MedChemComm · doi:10.1039/c5md00439j · Cited by 27
Guía de práctica clínica para el manejo del lupus eritematoso sistémico propuesta por el Colegio Mexicano de Reumatología
Xibille-Friedmann, D. X., Pérez‐Rodríguez, M., Carrillo-Vázquez, S. M., Hernández, E. A., Aceves, F. J., Ocampo-Torres, M. C., García-García, C., García‐Figueroa, J. L., Merayo‐Chalico, J., Barrera‐Vargas, A., et al. (2018) · Reumatología Clínica · doi:10.1016/j.reuma.2018.03.011 · Cited by 27
Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply
Medema, J. K., Zöllner, Y. F., Ryan, J. A., & Palache, A. M. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.006 · Cited by 27
Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states
Shefer, A. M., McKibben, L., Bardenheier, B. H., Bratzler, D. W., & Roberts, H. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2004.12.020 · Cited by 27
The Instrumental Variable Method to Study Self-Selection Mechanism: A Case of Influenza Vaccination
Yoo, B., & Frick, K. D. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00089.x · Cited by 26
Costs associated with influenza-related hospitalization in the elderly
Torner, N., Navas, E., Soldevila, N., Toledo, D., Navarro, G., Morillo, Á., Pérez, M. J., Domı́nguez, Á., & the Working Group of the Project PI12/02079 (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1264829 · Cited by 26
Knowledge and attitudes about influenza vaccination amongst general practitioners, practice nurses, and people aged 65 and over.
Brunton, C. R., Weir, R., & Jennings, L. (2004) · PubMed · Cited by 26
Patient Characteristics Determine Differences in the Influenza Vaccination Rate More so Than Practice Features
Tacken, M. A. J. B., Braspenning, J. C. C., Spreeuwenberg, P. M. M., van den Hoogen, H., van Essen, G. A., de Bakker, D. H., & Grol, R. P. T. M. (2002) · Preventive Medicine · doi:10.1006/pmed.2002.1083 · Cited by 26
If You Could Halve the Mortality Rate, Would You Do It?
Poland, G. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341404 · Cited by 25
[Neumonía acquired in the community. Practical guide elaborated by a committee intersocieties].
Luna, C. M., Calmaggi, A., Caberloto, O., Gentile, J., Valentini, R. N., Ciruzzi, J., Clara, L., Rizzo, O., Lasdica, S., Blumenfeld, M., et al. (2003) · PubMed · Cited by 26
A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population
Lee, B. Y., Ercius, A. K., & Smith, K. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.024 · Cited by 23
Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis
Yin, M., Huang, L., Zhang, Y., Yu, N. L., Xu, X., Liang, Y., & Ni, J. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1495077 · Cited by 25
Influenza
Forleo‐Neto, E., Halker, E., Santos, V. J., de Paiva, T. M., & Toniolo-Neto, J. (2003) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822003000200011 · Cited by 35
An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults
Valserra, M. D. B. D., Zanasi, A., Ragusa, S., Glück, R., & Herzog, C. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85008-1 · Cited by 25
Occasional review: Influenza in COPD: pathogenesis, prevention, and treatment
Wesseling, G. (2007) · International Journal of COPD · doi:10.2147/copd.2007.2.1.5 · Cited by 24
Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010–2011
Seo, Y. B., Hong, K., Kim, I. S., Choi, W. S., Baek, J. H., Lee, J., Song, J. Y., Lee, J. S., Cheong, H. J., & Kim, W. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.024 · Cited by 25
A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale
Gravenstein, S., Dahal, R., Gozalo, P. L., Davidson, H. E., Han, L., Taljaard, M., & Mor, V. (2016) · Clinical Trials · doi:10.1177/1740774515625976 · Cited by 24
Hospital Charges Attributable to a Primary Diagnosis of Infectious Diseases in Older Adults in the United States, 1998 to 2004
Curns, A. T., Steiner, C., Sejvar, J. J., & Schonberger, L. B. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01712.x · Cited by 24
Annual Influenza Vaccination in Community-Dwelling Elderly Individuals and the Risk of Lower Respiratory Tract Infections or Pneumonia
Voordouw, B. C. G. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.18.1980 · Cited by 24
Seasonal influenza vaccines: evolutions and future trends
Monto, A. S., & Ohmit, S. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.9 · Cited by 24
Experience with Oseltamivir in the Control of Nursing Home Influenza A Outbreak.
Shijubo, N., Yamada, G., Takahashi, M., Tokunoh, T., Suzuki, T., & Abe, S. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.366 · Cited by 23
Vaccine Prioritization for Effective Pandemic Response
Lee, E. K., Yuan, F., Pietz, F. H., Benecke, B. A., & Burel, G. (2015) · INFORMS Journal on Applied Analytics · doi:10.1287/inte.2015.0814 · Cited by 23
Further evidence for favorable cost-effectiveness of elderly influenza vaccination
Postma, M. J., Baltussen, R. M. P. M., Palache, A. M., & Wilschut, J. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.2.215 · Cited by 23
Life course vaccination and healthy aging
Gusmano, M. K., & Michel, J. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324907 · Cited by 23
Reactive arthritis after influenza vaccination: report of a case
Asakawa, J., Kobayashi, S., Kaneda, K., Ogasawara, H., Sugawara, M., Yasuda, M., & Hashimoto, H. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0399-5 · Cited by 23
Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions
AHMED, F., JANES, G., BARON, R., & Latts, L. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.11.020 · Cited by 23
Economic analyses of vaccine policies
Miller, M. A., & Hinman, A. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00072-0 · Cited by 23
Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons
Nichol, K. L., Nordin, J. D., & Mullooly, J. P. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.10.004 · Cited by 23
Influenza vaccination in Brazil: rationale and caveats
da Cunha, S. S., Camacho, L. A. B., Santos, A. C., & Dourado, I. C. (2005) · Revista de Saúde Pública · doi:10.1590/s0034-89102005000100017 · Cited by 22
Expanding the delivery of clinical preventive services through community collaboration: the SPARC model.
Shenson, D., Benson, W. F., & Harris, A. C. (2008) · PubMed Central · Cited by 22
Implementing an Influenza Vaccination Programme for Adults Aged ≥65 Years in Poland
Brydak, L. B., Roïz, J., Faivre, P., & Reygrobellet, C. (2011) · Clinical Drug Investigation · doi:10.2165/11594030-000000000-00000 · Cited by 22
Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease
Vila-Córcoles, Á., Ochoa, O., de Diego‐Cabanes, C., Valdivieso, A., Herreros, I. Z., Armant, F. B., Alvarez, M. M. R., Juárez, M., Guinea, I., Ansa, X., et al. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01414.x · Cited by 22
Lower respiratory tract infections: prevention using vaccines
Whitney, C. G., & Harper, S. A. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.07.008 · Cited by 21
Influenza vaccine coverage for healthcare workers in geriatric settings in France
Rothan‐Tondeur, M., de Wazières, B., Lejeune, B., & Gavazzi, G. (2006) · Aging Clinical and Experimental Research · doi:10.1007/bf03324852 · Cited by 21
Influence of influenza vaccination on recurrent hospitalization in patients with heart failure
TREAT-HF Investigators, Kaya, H., Beton, O., Açar, G., Temizhan, A., Çavuşoğlu, Y., Güray, Ü., Zoghi, M., Ural, D., Ekmekçi, A., et al. (2016) · Herz · doi:10.1007/s00059-016-4460-2 · Cited by 21
Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study
Liu, W.-C., Lin, C., Yeh, C.-C., Wu, H.-Y., Lee, Y., Chung, C., Cherng, Y., Chen, T.-L., & Liao, C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix616 · Cited by 21
Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI©) questionnaire
Chevat, C., Viala-Danten, M., Dias-Barbosa, C., & Nguyen, V. H. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-21 · Cited by 21
Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications
Boikos, C., Imran, M., Nguyen, V. H., Ducruet, T., Sylvester, G. C., & Mansi, J. A. (2021) · Vaccines · doi:10.3390/vaccines9080862 · Cited by 22
Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season
Poland, G. A., & Johnson, D. R. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.05.002 · Cited by 20
Influenza Immunization in Older Adults with and without Cancer
Locher, J. L., Rucks, A. C., Spencer, S. A., Pettaway, G. J., & Kilgore, M. L. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04196.x · Cited by 20
Discussions about preventive services: a qualitative study
Lasser, K. E., Kelly, B., Maier, J., Murillo, J., Hoover, S., Isenberg, K. B., Osber, D. S., Pilkauskas, N., Willis, B. C., & Hersey, J. (2008) · BMC Family Practice · doi:10.1186/1471-2296-9-49 · Cited by 20
The effect of a combined influenza/pneumococcal immunization reminder letter
Terrell-Perica, S., Effler, P. V., Houck, P. M., Lee, L., & Crosthwaite, G. H. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00372-5 · Cited by 20
Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012
Seo, Y. B., Choi, W. S., Baek, J. H., Lee, J., Song, J. Y., Lee, J. S., Cheong, H. J., & Kim, W. J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26858 · Cited by 20
Trends in influenza and pneumonia among older persons in the United States.
Gorina, Y., Kelly, T. N., Lubitz, J. D., & Hines, Z. (2008) · PubMed · Cited by 20
Chronic Obstructive Pulmonary Disease
Kerstjens, H., Postma, D., & Hacken, N. T. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5303 · Cited by 20
An Influenza Prevention Campaign: The Employee Perspective
Ludwig‐Beymer, P., & Gerc, S. C. (2002) · Journal of Nursing Care Quality · doi:10.1097/00001786-200204000-00003 · Cited by 20
Effects of influenza vaccination on mortality among frail, community-living elderly patients: An observational study
behalf of the SILVERNET-HC Study Group, Landi, F., Onder, G., Cesari, M., Gravina, E. M., Lattanzio, F., Russo, A., & Bernabei, R. (2003) · Aging Clinical and Experimental Research · doi:10.1007/bf03324506 · Cited by 20
An Overview of Systematic Reviews
Prins, M. H., ten Cate‐Hoek, A. J., & Leffers, P. (2008) · doi:10.1002/9781444300857.ch2 · Cited by 20
Pneumonia in Older Adults
File, T. M., & Tan, J. S. (2005) · JAMA · doi:10.1001/jama.294.21.2760 · Cited by 20
Influenza Vaccinations
Hak, E., Hoes, A. W., & Verheij, T. J. (2002) · Drugs · doi:10.2165/00003495-200262170-00001 · Cited by 19
Determinants of influenza vaccination timing
Yoo, B. K., & Frick, K. D. (2005) · Health Economics · doi:10.1002/hec.979 · Cited by 19
Inactivated influenza vaccination for people with spinal cord injury
Trautner, B. W., Atmar, R. L., Hulstrom, A., & Darouiche, R. O. (2004) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.03.022 · Cited by 18
Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly is advantageous: results from a budget impact analysis
Barbieri, M., Capri, S., de Waure, C., Boccalini, S., & Panatto, D. (2017) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2017.58.4.867 · Cited by 18
Influenza Vaccination Among Diabetic Adults
Jiménez‐García, R., Mayo-Montero, E., Hernández‐Barrera, V., Carrasco‐Garrido, P., Hernández, D. M., & de Miguel, Á. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2031 · Cited by 18
Influenza vaccination for healthcare workers: from a simple concept to a resistant issue?
Gavazzi, G. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324908 · Cited by 18
Are persons with diabetes practicing healthier behaviors in the year 2001? Results from the Behavioral Risk Factor Surveillance System
Okoro, C. A., Mokdad, A. H., Ford, E. S., Bowman, B. A., Vinicor, F., & Giles, W. H. (2003) · Preventive Medicine · doi:10.1016/j.ypmed.2003.09.039 · Cited by 18
Was gibt es Neues in der Behandlung der ambulant erworbenen Pneumonie?
Welte, T., Marre, R., Suttorp, N., & (CAPNETZ), F. D. K. „. E. P. (2006) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-006-1040-x · Cited by 18
Influenza and pneumococcal vaccination of the elderly in Taiwan
Chen, Y.-H., Liou, S., Chou, C.-C., Su, W., Loh, C., & Lin, S.-H. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.003 · Cited by 18
National availability of influenza vaccine among medical subspecialty practices
Davis, M. M., WORTLEY, P. M., Ndiaye, S. M., Woods, M. G., & Clark, S. J. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.12.016 · Cited by 16
Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology
Xibille-Friedmann, D. X., Pérez‐Rodríguez, M., Carrillo-Vázquez, S. M., Hernández, E. A., Aceves, F. J., Ocampo-Torres, M. C., García-García, C., García‐Figueroa, J. L., Merayo‐Chalico, J., Barrera‐Vargas, A., et al. (2018) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.03.003 · Cited by 17
Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations)
van Assen, S., & Bijl, M. (2012) · Lupus · doi:10.1177/0961203311429555 · Cited by 17
Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease.
Anar, C. M., Biçmen, C., Yapıcıoğlu, S., Ünsal, İ., Halilçolar, H., & Yılmaz, U. (2010) · PubMed · Cited by 17
Design of the Dutch Prevention of Influenza, Surveillance and Management (PRISMA) study
Hak, E., van Loon, S., Buskens, E., van Essen, G. A., de Bakker, D. H., Tacken, M. A. J. B., van Hout, B. A., Grobbee, D. E., & Verheij, T. J. M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00520-0 · Cited by 17
Vacinação contra influenza em idosos por área de residência: prevalência e fatores associados
Francisco, P. M. S. B., Donalísio, M. R., Barros, M. B. D. A., César, C. L. G., Carandina, L., & Goldbaum, M. (2006) · Revista Brasileira de Epidemiologia · doi:10.1590/s1415-790x2006000200003 · Cited by 17
Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?
Bower, H., Frisell, T., Giuseppe, D. D., Delcoigne, B., & Askling, J. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221461 · Cited by 15
Role of vaccinations and prophylaxis in rheumatic diseases
Papadopoulou, D., Tsoulas, C., Tragiannidis, A., & Sipsas, N. V. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.02.001 · Cited by 15
Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease
Schulte, K., Schierke, H., Tamayo, M., Hager, L., Engehausen, R., Raspe, M., Hübner, R., Schlieper, G., Borzikowsky, C., Urbschat, A., et al. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0413 · Cited by 15
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
Seo, Y. B., Moon, S., Jeon, C. H., Song, J. Y., Sung, Y., Jeong, S. J., Kwon, K. T., Kim, E. S., Kim, J.-H., Kim, H., et al. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.2.252 · Cited by 15
Influenza Vaccination in Adults with Chronic Obstructive Pulmonary Disease: The Impact of a Diagnostic Breathing Test on Vaccination Rates
Mowls, D. S., Cheruvu, V. K., & Zullo, M. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067600 · Cited by 15
Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults
Raviotta, J. M., Smith, K. J., DePasse, J. V., Brown, S. T., Shim, E., Nowalk, M. P., Wateska, A. R., France, G., & Zimmerman, R. K. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.069 · Cited by 15
Effectiveness of influenza vaccination in the elderly in South Africa
van Vuuren, A., Rheeder, P., & Hak, E. (2008) · Epidemiology and Infection · doi:10.1017/s0950268808001386 · Cited by 15
Variaciones estacionales en la morbimortalidad por tromboembolismo pulmonar en Galicia
Santiago, J. M., García, G. M. R., & Domínguez, A. M. (2003) · Anales de Medicina Interna · doi:10.4321/s0212-71992003000900003 · Cited by 15

Authors: Nichol, K. L., Wuorenma, J., & von Sternberg, T.
Affiliations: University of Minnesota (US)
Regions Hospital (US)
Venue: Archives of Internal Medicine
Publisher: American Medical Association (AMA)
Published: 1998-09-14
Volume: 158
Issue: 16
Pages: 1769
ISSN: 0003-9926 (ISSN-L)
DOI: 10.1001/archinte.158.16.1769
OpenAlex: W2056095352
Cited by: 484
References: 41
Citations by year: 2025: 3 · 2024: 1 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 14 · 2017: 15 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 9 · 2012: 16
FWCI: 15.05
Type: journal article
Language: en
Open access: closed
Locations: Archives of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Social Sciences › Health › Vaccine Coverage and Hesitancy
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords: influenza vaccination, older adults, vaccine effectiveness, pneumonia hospitalization, respiratory hospitalization, congestive heart failure, all-cause mortality, risk stratification, cost reduction, vaccination coverage, health maintenance organizations, diabetes mellitus, kidney disease, dementia, rheumatic diseases
MeSH terms: Aged, Aged, 80 and over, Female, Humans, Influenza, Human, Influenza Vaccines, Male, Risk, Risk Factors, Seasons, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks